Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Neoplasms × ABTL0812 × Clear all

Phase

Status

Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Neoplasms 1 Endometrial Neoplasms 1

Interventions

Gemcitabine 356 Fluorouracil 93 Oxaliplatin 81 Capecitabine 74 Albumin-Bound Paclitaxel 69 130-nm albumin-bound paclitaxel 69 Radiotherapy 67 Leucovorin 57 Irinotecan 48 Erlotinib Hydrochloride 47 Cisplatin 44 Bevacizumab 31 Radiosurgery 30 pembrolizumab 29 Docetaxel 26 Taxes 24 Nivolumab 24 Cetuximab 24 Pancreaticoduodenectomy 20 Drug Therapy 17 Cyclophosphamide 17 folfirinox 16 Radiation 15 Endoscopic Ultrasound-Guided Fine Needle Aspiration 13 Surgical Procedures, Operative 12 Sorafenib 12 Paclitaxel 12 Neoadjuvant Therapy 12 Ipilimumab 12 irinotecan sucrosofate 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04431258 2024-03-18

PanC-ASAP

Ability Pharmaceuticals SL

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡